Home > News > Recent cases

Recent cases

Sandoz & Anr v Bristol-Myers Squibb & Ors [2022] EWHC 1831 (Pat)15 July 2022Andrew Lykiardopoulos QC appeared for Sandoz and Justin Turner QC appeared for Teva  in proceedings to invalidate 4 patents owned by Bristol-Myers Squibb (“BMS”) and Pfizer, both of whom counterclaimed that the generic products which Sandoz and Teva intended to launch on the UK market would infringe. The patents related to a formulation of apixaban […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 1641 (Pat)29 June 2022Charlotte May QC and Henry Ward successfully appeared for the defendant (“Teva”) in a second application brought by the claimants (“Neurim”) for interim injunctive relief, the first application (also successfully defended by Charlotte May QC) having been rejected by Mellor J on 14 April 2022.  The underlying claim related to infringement of Neurim’s patent for […]
Alcon Research v Pharmathen [2022] EWCA Civ 84528 June 2022Lindsay Lane KC and William Duncan appeared for the second defendant (“Aspire”) in an appeal of the judgment of Meade J finding that a patent for the use of fluprostenol isopropyl ester (“FIE”), a prostaglandin F2α (“PGF2α”) analogue, also known as travoprost, for the treatment of glaucoma and ocular hypertension was valid and infringed.  The […]
Shazam v Only Fools The Dining Experience [2022] EWHC 1379 (IPEC)8 June 2022Shazam, the company holding the rights in the sitcom Only Fools and Horses previously owned by its creator, John Sullivan, sued Only Fools The Dining Experience (‘OFDE’) and related companies and individuals for using characters, catchphrases, themes and other material taken from the sitcom in their immersive theatrical dining experience “Only Fools The (cushty) Dining […]
Advanced Bionics AG & Anr v Med-El Elektromedizinische Geräte Gmbh [2022] EWHC 1345 (Pat)1 June 2022Andrew Lykiardopoulos QC appeared as lead counsel for the claimants (“Advanced Bionics”) in proceedings brought against the defendant (“Med-El”) to revoke a patent relating to MRI-safe disk magnets and/or a declaration that Advanced Bionics’ implant device did not infringe.  Med-El counterclaimed for infringement, with the proceedings conducted through the Shorter Trials Scheme. The trial in […]
Saint-Gobain Adfors SAS v 3M Innovative Properties Co [2022] EWHC 1018 (Pat)9 May 2022James Abrahams QC and Michael Conway successfully appeared for the claimant (“Saint-Gobain”) in a claim to revoke a European patent (“the Patent”) registered by the defendant (“3M”) for dish-shaped abrasive particles with a recessed surface. The Patent claimed that dish-shaped abrasive particles, with a sloping sidewall and a specific thickness ratio, increase the grinding performance […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 954 (Pat)26 April 2022Charlotte May QC successfully appeared as lead counsel for the defendant (“Teva”) in opposing an application for an interim injunction brought by the claimants (“Neurim”) for an order restraining Teva from disposing of, offering for sale, selling or supplying a generic version of Circadin. The hearing of the application had been expedited by Roth J. […]
Alcon Eye Care UK Ltd & Anr v AMO Development LLC [2022] EWHC 955 (Pat)26 April 2022Michael Tappin QC and Henry Ward appeared for the defendant and patentee (“AMO”) in legal proceeding brought by the claimants (“Alcon”) to revoke two patents for ophthalmic surgical systems used for carrying out cataract surgery.  Alcon’s validity attack was based on obviousness and insufficiency.  AMO counterclaimed for infringement of the patents by Alcon’s LenSx laser […]
easyGroup Ltd -v- Nuclei Ltd (t/a Easy Offices) & Ors [2022] EWHC 901 (Ch)13 April 2022Jaani Riordan successfully appeared as junior counsel led by Mark Vanhegan QC for the defendants (collectively, “Nuclei”) in proceedings brought by the claimant (“easyGroup”) alleging infringement of four EU and UK trade marks for EASYOFFICE in various forms (“the Trade Marks”).  The Trade Marks were registered in relation to services including hire and rental of […]
Sandoz Ltd & Ors v Bristol-Myers Squibb Holdings [2022] EWHC 822 (Pat)7 April 2022Michael Tappin QC appeared as lead counsel for Sandoz in proceedings brought with Teva to revoke a patent owned by Bristol-Myers Squibb (“BMS”).  BMS counterclaimed for infringement, which, in the event that the patent was found to be valid, Sandoz and Teva admitted. The patent related to the compound apixaban sold by BMS under the […]